Acceleron Pharma, Inc. (NASDAQ: XLRN) Shares Jump on Drug Exposure: U.S. Daily Market Movers

Published:

Small cap
stocks making big moves on Monday, December 8, 2014 (as of 4 pm EST), as
reported by Hassan Malik, SmallCapPower.com

Acceleron Pharma,
Inc.

(NASDAQ: XLRN)
shares surged 13% to $42.51 on Monday after two of the company’s experimental
drugs, which are designed to boost red blood cell production in patients with
anemia caused by rare blood disorders, were featured in media session at
the American Society of Hematology (ASH) annual meeting over the weekend.

As well,
shares of Compugen Ltd. (NASDAQ: CGEN)
climbed 4% to $8.33 as the therapeutic product discovery company realized one
positive estimate revision in the last 60 days. The Zacks Consensus Estimate
has also moved higher over the same period. Currently, Compugen has a Zacks
Rank of #2 (Buy).

Liquidity Services, Inc. (NASDAQ: LQDT)
stock, meanwhile, sank 27% to $7.49 after Bank of America’s analyst Nat
Schindler reiterated his “Underperform” rating on Liquidity Services shares,
but lowered the price target from $11 to $9. Recently, Liquidity revealed a
termination notice from Walmart (its largest retail partner). The termination
notice is effective Monday, December 8, 2014, though Liquidity does not expect
the termination to impact Q4 results.

Related articles

Recent articles